Innovative solutions for human benefit
in the fields of cancer, dermatology
and regenerative medecine

"We are driven by a commitment to improving human health. 15 years ago no one else believed that 3D human tissue models would become indispensable to medicine. CTIBiotech were the first to make that vision a reality"
Professor Colin McGuckin
Chairman & CSO

World renowned cancer researcher & pioneer in regenerative medicine.
Expert in stem cells, governement advisor, medical journal reviewer.

3 POLES OF EXCELLENCE

95% of new drug candidates fail cancer clinical trials, costing billions to the pharmaceutical industry and delaying new treatments for patients.

Robust predictive human cell bioassays support faster development of preclinical trials thereby saving time and money.

We offer: R&D, drug testing, medical device co-development and testing, bioassay co-conception and open lab. We provide fully functioning 3D tissue models and specific cell models from patients which improves efficacy given their proximity to human physiology.

For: Pharmaceutical industry (cancer research, regenerative medicine, medical devices), public and private research institutions, contract research organisations.

Key product innovations:

  • • World’s first mini liver as part of a NASA research programme
  • • World’s first nervous tissue model
  • • Stem cell applications
  • • 3D microtumours

95% of new drug candidates fail cancer clinical trials, costing billions to the pharmaceutical industry and delaying new treatments for patients

Robust predictive human cell bioassays support faster development of preclinical trials thereby saving time and money

Efficient cosmetics and skin care products require innovation and claim substantiation.

Human skin models provide the means to test new product ideas with scientific credibility.

We offer: In house tests, off the shelf models, co-development/innovation. Open lab using complex skin models from any age range and typology. Skin biopsies and in-house research.

For: Cosmetic and dermatology industries

Key product innovations:

  • • Ex vivo baby skin models
  • • In vitro hair models
  • • Sebaceous gland models
  • • Pigmentation models
  • • Scar and stretch marks models
  • • Sensitive skin models

95% of new drug candidates fail cancer clinical trials, costing billions to the pharmaceutical industry and delaying new treatments for patients

Robust predictive human cell bioassays support faster development of preclinical trials thereby saving time and money

Top quality human cells, tissues and biological samples that provide the basis for research and innovation.

  • • National biobank for cancer
  • • International biobank for clients and partners

We offer: Human biological sample procurement & cell harvesting. Over 50 000 tissue samples in stock or on demand from bio-sourcing via a network of 200 healthcare partners worldwide

Specifically this includes:

  • • Human skin cells (dermal, epidermal, melanocytes, sebocytes ...)
  • • Oral and facial cells and tissues
  • • Subcutaneous tissues and organs
  • • Blood and bone marrow
  • • Cancer and associated cells
  • • Pathological tissues
  • • Cell purification and characterisation (CD34, 56, T, B)


Key product innovations:

  • • 3D printed tissue models
  • • Animal product free human cell models
MORE INFORMATION
fond

LATEST INNOVATIONS

CTISkin® Ex Vivo

The Ex vivo kit from CTISkin® is a standardised and ready to use solution for your efficacy and safety tests. Collected just after the surgical intervention, we provide you with the freshest possible skin biopsies that can be used up to 11 days.

LEAFLET

CTISkin® Ex Vivo - Video Protocol

Watch our latest video about the protocol after reception of your CTISkin® Ex Vivo Kit.

CTISkin® Single Donor Kit

Working with human primary cells from different donors may lead to biological variations.
The CTISkin® Single donor kit gives you access to human primary cells from one donor to support your in vitro bioassays compliant with ethics and regulatory standards.

LEAFLET

3D printed micro-tumour

Using the latest tools in bioengeneering, our researchers are now printing cancer tissues in 3D. These models can be used for highly significant pre-clinical trials and can be produced in 6/48/96 well plates for high throughput screening.

Advanced 3D skin models

Test your active ingredients, cosmetics, and dermatology products on advanced models and add credibility to substantiate efficiency claims for discerning customers. Donors can be selected by gender, age, phototype.

Open Lab

Use of our 1 000 m² state of the art R&D facilities with access to CTIBiosourcing and a highly trained team of international researchers located just 10 minutes from Lyon International Airport.

CONTACT

T +33 9 67 10 74 55
CTIBiotech
Bat A16, 5 avenue Lionel Terray,
69330 Meyzieu
Lyon, France
Locate us on Google Maps

For questions and enquiries, please use the form below